文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜后上段肝切除术后并发症危险因素分析

What matters in laparoscopic hepatectomy for lesions located in posterosuperior segments? Initial experiences and analysis of risk factors for postoperative complications: a retrospective cohort study.
PubMed 文献 · Surg Endosc · 2025-04-30

该回顾性队列研究纳入110例因后上段(VII、VIII、IVa段)病灶行腹腔镜肝切除的患者,分析临床相关术后并发症(Clavien-Dindo≥III级)的危险因素。多因素分析显示ASA≥III级、糖尿病及术中输注浓缩红细胞是独立危险因素。

要点

  • ASA≥III级、糖尿病、术中输注浓缩红细胞增加Clavien-Dindo≥III级并发症风险。
  • 术前应优化糖尿病管理并筛查贫血,对ASA≥III级患者充分告知风险。
  • 围术期应尽量减少术中浓缩红细胞输注。

核心结论

  • ASA≥III级、糖尿病和术中输注浓缩红细胞与后上段腹腔镜肝切除患者发生Clavien-Dindo≥III级并发症风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入2018年4月至2022年10月期间至少一处病灶位于后上段(VII、VIII、IVa段)的行腹腔镜肝切除的110例患者,采用二元logistic回归进行单因素和多因素分析。

主要发现

  • 110例患者中位年龄67岁(IQR 59-76),男性占62%(n=68),中位BMI 26(IQR 23-30)。
  • 最常见手术指征为原发性肝癌(37%)和结直肠癌肝转移(36%)。
  • 中位手术时间211分钟(IQR 135-281),中位失血量460 mL(IQR 240-1200),术后中位住院时间6天(IQR 4-8)。
  • 20例(18%)发生临床相关术后并发症,90天死亡率为5%(n=6)。
  • 多因素分析显示ASA≥III级(OR 3.23 [95%CI 1.03-10.09]; p=0.043)、糖尿病(OR 4.31 [95%CI 1.20-15.49]; p=0.025)和术中输注浓缩红细胞(OR 4.80 [95%CI 1.01-22.86]; p=0.049)是Clavien-Dindo≥III级并发症的危险因素。

临床怎么用

  • 术前应优化糖尿病管理,筛查贫血并适当补充。
  • 对ASA≥III级患者进行全面的风险告知。
  • 围术期应尽量减少术中浓缩红细胞输注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver resection (LLR) for lesions in the posterosuperior segments (PSS) is challenging. Identifying and minimizing risk factors for postoperative morbidity and mortality is crucial. This retrospective cohort study shares initial experiences with LLR of the PSS (VII, VIII, IVa) and wants to identify risk factors for clinically relevant postoperative complications (Clavien-Dindo grade ≥ III) in these patients. METHODS: We reviewed our prospective database for all patients who underwent LLR with at least one lesion in the PSS (April 2018-October 2022). Uni- and multivariate analyses were carried out using binary logistic regression analysis. RESULTS: 110 patients underwent LLR of the PSS. Median age was 67 years (IQR 59-76); 62% were male (n = 68), with a median BMI of 26 (IQR 23-30). The most frequent indications for LLR were primary liver cancer (37%) and colorectal liver metastasis (36%). Median operating time was 211 min (IQR 135-281) with a median blood loss of 460 mL (IQR 240-1200). Postoperative length of stay was 6 days (IQR 4-8). Clinically relevant postoperative complications were present in 20 patients (18%) with a 90-day mortality rate of 5% (n = 6). Multivariate analyses identified ASA ≥ III (OR 3.23 [95%CI 1.03-10.09]; p = 0.043), diabetes (OR 4.31 [95%CI 1.20-15.49]; p = 0.025), and intraoperative transfusion of packed red blood cells (PRBC) (OR 4.80 [95%CI 1.01-22.86]; p = 0.049) as risk factors for Clavien-Dindo grade ≥ III complications. CONCLUSION: ASA ≥ III status, diabetes, and intraoperative PRBC transfusion are associated with an increased risk of Clavien-Dindo grade ≥ III complications in patients undergoing LLR in PSS. Preoperative optimization should include diabetes management, screening for anemia with appropriate supplementation, and comprehensive risk counseling for ASA ≥ III patients. Additionally, minimizing intraoperative PRBC transfusion should remain a key perioperative goal.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Téoule P, Dunker N, Gölz V, et al. What matters in laparoscopic hepatectomy for lesions located in posterosuperior segments? Initial experiences and analysis of risk factors for postoperative complications: a retrospective cohort study. Surg Endosc. 2025. PMID: 40307470. doi:10.1007/s00464-025-11674-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。